Search Results - "Chundi, Vishnu V"
-
1
Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2
Published in Clinical and translational science (01-11-2021)“…Tocilizumab is an IL‐6 receptor antagonist with the ability to suppress the cytokine storm in critically ill patients infected with severe acute respiratory…”
Get full text
Journal Article -
2
SARS-CoV2 and Co-Infections: A Review of Two Cases
Published in Case reports in infectious diseases (26-09-2020)“…COVID-19 infection caused by SARS-CoV2 virus is an acute respiratory illness which was declared as a pandemic by the World Health Organization. Usually,…”
Get full text
Journal Article -
3
Persistent SARS-CoV-2 infectivity greater than 50 days in a case series of allogeneic peripheral blood stem cell transplant recipients
Published in Current problems in cancer. Case reports (01-03-2021)“…The coronavirus disease 19 (COVID-19) pandemic has infected tens of millions across the world, but there is a significant gap in our understanding about…”
Get full text
Journal Article -
4
Value and Clinical Impact of an Infectious Disease-Supervised Outpatient Parenteral Antibiotic Therapy Program
Published in Open forum infectious diseases (01-10-2016)“…Outpatient parenteral antibiotic therapy (OPAT) is a safe and effective modality for treating serious infections. This study was undertaken to define the value…”
Get full text
Journal Article -
5
Persistent SARS-CoV-2 infectivity greater than 50 days in a case series of allogeneic peripheral blood stem cell transplant recipients
Published in Current problems in cancer. Case reports (01-03-2021)“…The coronavirus disease 19 (COVID-19) pandemic has infected tens of millions across the world, but there is a significant gap in our understanding about…”
Get full text
Report -
6
SARS-CoV2 and Co-Infections: A Review of Two Cases
Published in Case reports in infectious diseases (01-01-2020)Get full text
Report